Clarithromycin in treatment of early Lyme disease: A pilot study

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 2, 1996, Pages 468-469

  Dattwyler, Raymond J ^a   Grunwaldt, Edgar ^b   Luft, Benjamin J ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CEFUROXIME; CLARITHROMYCIN; DOXYCYCLINE; ROXITHROMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BORRELIA BURGDORFERI; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DIARRHEA; DOSE RESPONSE; FATIGUE; FEMALE; HEADACHE; HUMAN; LYME DISEASE; MALAISE; MALE; MUCOSA INFLAMMATION; MYALGIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TASTE AVERSION; TREATMENT OUTCOME; VOMITING;

EID: 0030048104     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.2.468     Document Type: Article

References (13)

1. Alder, J., M. Mitten, K. Jarvis, P. Gupta, and J. Clement. 1993. Efficacy of clarithromycm for treatment of experimental Lyme disease in vivo. Antimicrob. Agents Chemother. 37:1329-1333.
2. Berger, B. W. 1988. Treatment of erythema chronicum migrans of Lyme disease. Ann. N.Y. Acad Sci. 539:346-351.
3. Berger, B. W. 1993. Lyme disease. Semin. Dcrmatol. 12:357-362.
4. Buchstein, S. R., and P. Gardner. 1991. Lyme disease. Infect. Dis. Clin. N. Am. 5:103-116.
5. Centers For Disease Control and Prevention. 1993 Lyme disease - United States 1991-1992. Morbid. Mortal. Weekly Rep. 42:345-350
6. Dattwyler, R. J., D. J. Volkman, S. M. Conaty, S. P. Platkin, and B. J. Luft. 1990. Treatment of early Lyme borreliosis, a randomized trial comparing amoxicillin plus probenecid to doxycycline in patients with erythema migrans. Lancet 336:1404-1406.
7. Gross, B. 1989. Comparative antimicrobial activity of the new macrolides against Borrelia burgdorferi. Eur J. Clin. Microbiol. Infect. Dis. 8:651-653.
8. Hovmark, A., I. Olsson, E. Asbrink, E. Olsson, L. Halkier-Sorensen, and K. Hansen. 1990. A comparative study of the efficacy of roxithromycin and phenoxymethyl-penicillin in the treatment of erythema migrans, p, 161. In Abstracts of the Proceedings of the IV International Conference on Lyme Borreliosis Karolinska Institute, Stockholm.
9. Johnson, R. C., C. Kodner, M. Russell, and D. Girard. 1990 In vitro and in vivo susceptibility of Borrelia burgdorferi to azithromycin. J. Antimicrob. Chemother. 25(Suppl. A):33-38.
10. Massarotti, E. M., S. W. Luger, D. W. Rahn, et al. 1992 Treatment of Lyme disease. Am. J Med 92:396-403.
11. Preac-Mursic, V., B. Wilske, G. Schierz, E. Suss, and B. Gross. 1989. Comparative antimicrobial activity of new macrolides against Borrelia burgdorferi. Eur J. Clin. Microbiol. Infect Dis. 8:651-653.
12. U.S. Department of Health and Human Services. 1990 COSTART coding symbols of thesaurus of adverse reaction terms, 3rd ed. U.S. Food and Drug Administration. Rockville, Md
13. Weber, K., U. Neubert, and R. Thurmayr. 1986. Antibiotic therapy in early erythema migrans disease and related disorders. Zentralbl. Bakteriol. Mikrobiol. Hyg. A 263:377-388.